Anti-cancer drug’s mode of operation deciphered

BIOSS researchers show how the membrane protein CD20 keeps the immune system’s antibody-producing cells in check Freiburg researchers investigate how the membrane protein CD20 organizes the nanostructures on the B cell membrane. Illustration: Julia Jellusova Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists […]